US FDA’s OCI Director Is Leaving For Private Practice

George Karavetsos’ last day is Jan. 20, which coincidentally is the start of the Trump Administration. Office of Criminal Investigations has been subject of recent Congressional scrutiny.

FDA entrance sign 2016

More from US FDA

More from Agency Leadership